GTG is an Australia-based biotechnology firm that provides solutions such as DNA genetic research and molecular risk assessment for physicians to treat patients with cancer.
Business Model:
Revenue: $17.5k
Employees: 11-50
Address: 60-66 Hanover Street
City: Fitzroy
State: victoria
Zip: 3065
Country: AU
GTG is an Australia-based biotechnology firm that provides solutions such as DNA genetic research and molecular risk assessment for physicians to treat patients with cancer.
Contact Phone:
Contact Email:
Listed Exchange:
Australian Securities Exchange
IPO Date:
7/30/1999
Ticker Symbol:
GTG
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Private Placement | $6.6M | 7/2020 | Post-IPO Equity | $5.1M | 8/2013 | Private Placement | $800k | 5/2020 | Post-IPO Equity | $8M | 7/2013 | Private Placement | $2.2M | 1/2015 | Private Placement | $19.6M |
Kentgrove Capital Pty Ltd |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|